Your browser doesn't support javascript.
loading
Immunology of SARS-CoV-2 Infection.
Gabdoulkhakova, Aida G; Mingaleeva, Rimma N; Romozanova, Albina M; Sagdeeva, Aisylu R; Filina, Yulia V; Rizvanov, Albert A; Miftakhova, Regina R.
Afiliação
  • Gabdoulkhakova AG; Kazan Federal University, Kazan, 420008, Russia. AiGGabdulhakova@kpfu.ru.
  • Mingaleeva RN; Kazan State Medical Academy - Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Health of the Russian Federation, Kazan, 420012, Russia.
  • Romozanova AM; Kazan Federal University, Kazan, 420008, Russia.
  • Sagdeeva AR; Kazan Federal University, Kazan, 420008, Russia.
  • Filina YV; Kazan Federal University, Kazan, 420008, Russia.
  • Rizvanov AA; Kazan Federal University, Kazan, 420008, Russia.
  • Miftakhova RR; Kazan Federal University, Kazan, 420008, Russia.
Biochemistry (Mosc) ; 89(1): 65-83, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38467546
ABSTRACT
According to the data from the World Health Organization, about 800 million of the world population had contracted coronavirus infection caused by SARS-CoV-2 by mid-2023. Properties of this virus have allowed it to circulate in the human population for a long time, evolving defense mechanisms against the host immune system. Severity of the disease depends largely on the degree of activation of the systemic immune response, including overstimulation of macrophages and monocytes, cytokine production, and triggering of adaptive T- and B-cell responses, while SARS-CoV-2 evades the immune system actions. In this review, we discuss immune responses triggered in response to the SARS-CoV-2 virus entry into the cell and malfunctions of the immune system that lead to the development of severe disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Biochemistry (Mosc) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Biochemistry (Mosc) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Federação Russa